Skip to content

Clinical outcomes of refractory neovascular glaucoma after anti VEGF treatment

The efficacy of neovascular glaucoma management with anti-vascular endothelial growth factor in eyes undergoing pars plana vitrectomy, complement pan-retinal photocoagulation and endoscopic cyclophotocoagulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057952
Enrollment
Unknown
Registered
2022-03-24
Start date
2022-03-24
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neovascular glaucoma

Interventions

Endoscopic ciliary photocoagulation:Endoscopic ciliary photocoagulation
Amed glaucoma valve implantation:Amed glaucoma valve implantation

Sponsors

Third Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with angle closure neovascular glaucoma. 1. Eye pain, headache, high intraocular pressure (>=21mmHg); 2. Low vision, new blood vessels found in the iris or atrial angle; 3. Slit lamp examination showed that the cornea was transparent and there was no inflammatory reaction in the anterior segment; 4. Posterior segment was examined under fundus microscope to exclude other eye diseases; 5. Have a certain level of education, fully understand the significance and risks of clinical trials, agree and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. With other serious systemic diseases, pregnant and lactating women, with a history of drug abuse and alcoholism; 2. Those with other eye diseases, such as iridocyclitis, keratitis, ocular trauma, and secondary glaucoma.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;Best corrected visual acuity;

Secondary

MeasureTime frame
Degree of eye pain;

Countries

China

Contacts

Public ContactHou baoke

Third Medical Center of PLA General Hospital

bookee@126.com+86 13521403303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026